Hospital Universitario La Paz-ko ikertzaileekin lankidetzan egindako argitalpenak (373)

2024

  1. Pre-exposure prophylaxis of non-HIV viral infections and the role of long-acting antivirals

    AIDS reviews, Vol. 25, Núm. 4, pp. 162-172

  2. Strengthen the doctor-patient relationship and avoid administrative stifling

    AIDS Reviews, Vol. 26, Núm. 2, pp. 64-66

2023

  1. Adult T-cell leukemia/lymphoma in HTLV-1 non-endemic regions

    Journal of Clinical Virology, Vol. 167

2022

  1. Trends in hospitalizations and deaths in HIV-infected patients in Spain over two decades

    AIDS, Vol. 36, Núm. 2, pp. 249-256

2020

  1. Advances in hepatitis B therapeutics

    Therapeutic Advances in Infectious Disease, Vol. 7

  2. COVID-19 comes 40 years after aids – Any lesson?

    AIDS Reviews, Vol. 22, Núm. 1, pp. 1-15

  3. Covid-19 comes 40 years after aids – any lesson?

    AIDS Reviews, Vol. 22, Núm. 2, pp. 63-77

  4. Hospital admissions in individuals with HTLV-1 infection in Spain

    AIDS, Vol. 34, Núm. 7, pp. 1019-1027

  5. Hot news: Unveiling long COVID-19 disease

    AIDS Reviews

  6. Impact of new coronavirus epidemics on HIV-infected patients

    AIDS Reviews

  7. Rapid antigen Testing and Mask Wearing While Waiting for COVID-19 Vaccines

    AIDS reviews, Vol. 22, Núm. 3, pp. 168-172

2019

  1. Clinical experience with integrase inhibitors in HIV-2-infected individuals in Spain

    Journal of Antimicrobial Chemotherapy, Vol. 74, Núm. 5, pp. 1357-1362

  2. Clinical presentation of individuals with human T-cell leukemia virus type-1 infection in Spain

    Open Forum Infectious Diseases, Vol. 6, Núm. 2

  3. HIV-2 molecular epidemiology in Spain: 30 years since the first case

    VIRUS EVOLUTION

  4. Occult hepatitis B and HIV infection

    European Journal of Gastroenterology and Hepatology, Vol. 31, Núm. 11, pp. 1403-1407

2018

  1. AIDS clinical research in spain—large HIV population, geniality of doctors, and missing opportunities

    Viruses, Vol. 10, Núm. 6

  2. Decline and changing profile of hepatitis delta among injection drug users in Spain

    Antiviral Therapy, Vol. 23, Núm. 1, pp. 87-90

  3. Hepatitis Delta Enters a New Therapeutic Era

    Journal of Infectious Diseases

  4. Increased indoleamine-2,3-dioxygenase activity is associated with poor clinical outcome in adults hospitalized with influenza in the INSIGHT FLU003Plus study

    Open Forum Infectious Diseases, Vol. 5, Núm. 1

  5. Prevalence and incidence of hepatitis delta in patients with chronic hepatitis B in Spain

    European Journal of Gastroenterology and Hepatology, Vol. 30, Núm. 9, pp. 1060-1062